I now have rich content from Barash's Pediatric Anesthesia chapter. The truncated output also included key induction/maintenance details. Let me now compile the comprehensive anaesthesia plan.
Anaesthesia Plan: 3-Year-Old, 10 kg Child
(Assuming an otherwise healthy child presenting for elective surgery with no specified comorbidities. Adapt based on procedure, ASA status, and local protocol.)
1. Preoperative Assessment
Key checks:
- ASA classification, full history including birth history, prior anaesthesia, family history of MH or pseudocholinesterase deficiency
- Airway assessment: look for syndromes associated with difficult airway (Pierre Robin, Down syndrome, Treacher Collins). At 3 years, the airway is maturing but still differs from adults - large occiput, large tongue relative to oral cavity, anterior larynx, narrowest point at subglottis
- Recent URTI: if active URTI with productive cough or fever, consider deferring 2-4 weeks (increased PRAEs - laryngospasm, bronchospasm, oxygen desaturation)
- Nil-by-mouth status: clear fluids up to 1 hour before, breast milk 4 hours, formula/solids 6 hours (2023 revised fasting guidelines used at many centres; confirm local policy)
- Haemoglobin if significant blood loss expected
Weight-based estimates (10 kg):
- ETT size: uncuffed = age/4 + 4 = 4.0 mm (or cuffed 3.5 mm); confirm with depth = (age/2 + 12) = ~13-14 cm at lips
- LMA size: LMA #2 (suitable for 10-20 kg)
- Blood pressure cuff: small child size
2. Premedication
- Midazolam oral: 0.3-0.5 mg/kg PO (max 15 mg), ~30 min before induction - effective anxiolysis for a 3-year-old who is likely in "stranger anxiety" developmental stage
- Alternatively: dexmedetomidine intranasal 1-2 mcg/kg if IV access already in place or oral route not feasible
- Paracetamol (acetaminophen) oral: 15 mg/kg = 150 mg PO as premedication for multimodal analgesia
- EMLA/Ametop cream over potential IV sites (dorsum of hand) if IV induction planned
3. Induction
Route of choice: Inhalational induction (preferred in uncooperative 3-year-olds without IV access)
- Sevoflurane is the agent of choice: pleasant smell, non-pungent, rapid wash-in due to low blood-gas solubility, cardiovascular stability
- Start at 8% sevoflurane in 100% O₂ using a well-fitting mask with flavouring
- Reduce to 4-6% once unconscious
- MAC for sevoflurane in a 3-year-old ≈ 2.5% (higher than adults)
- Wash-in is faster in children than adults (higher alveolar ventilation-to-FRC ratio, greater VRG perfusion)
- Once IV access secured (large antecubital or dorsal hand vein), transition to IV agents as needed
If IV access secured first (e.g., pre-existing line):
- Propofol IV: 3.5-5.4 mg/kg (ED90 for LMA insertion = 5.4 mg/kg) = 35-54 mg; the 50% higher dosing compared to adults is required in young children to achieve target brain concentration of ~3 mcg/mL
- For tracheal intubation: Propofol 1-2 mg/kg with sevoflurane, or add fentanyl 1-2 mcg/kg (= 10-20 mcg) to blunt intubation response
Muscle relaxant (if intubating):
- Atracurium 0.5 mg/kg IV = 5 mg (preferred in children - spontaneous non-enzymatic Hofmann elimination, no organ dependence)
- Or rocuronium 0.6 mg/kg = 6 mg (reversible with sugammadex 16 mg/kg for RSI dose)
- Avoid suxamethonium routinely in children - risk of hyperkalaemia from undiagnosed myopathies (e.g., Duchenne MD); reserve for RSI or laryngospasm emergency
- Suxamethonium RSI dose: 2 mg/kg IV (= 20 mg) if RSI specifically indicated
Atropine: Keep at hand - 0.02 mg/kg IV = 0.2 mg (minimum 0.1 mg); children are prone to vagally-mediated bradycardia during intubation and at induction
4. Airway Management
- LMA size 2 (10-20 kg) is appropriate for most elective procedures; allows spontaneous ventilation and avoids risks of intubation
- ETT if required (head and neck, abdominal, laparoscopic, RSI, or prolonged procedure):
- Cuffed ETT 3.5 mm (preferred by most modern guidelines to allow low leak pressures and reduce repeated laryngoscopy)
- Uncuffed ETT 4.0 mm if no cuffed available
- Confirm position with capnography and bilateral breath sounds
- Aim leak pressure 15-25 cmH₂O if using uncuffed tube
- Laryngoscope: Straight blade (Miller 1 or Macintosh 1) - useful in younger children to elevate floppy epiglottis
- Head position: Neutral to slight sniffing (avoid overextension - can obstruct the relatively anterior paediatric larynx)
- Stylet/bougie and smaller ETT (3.5 uncuffed, 3.0) readily available
5. Maintenance of Anaesthesia
Option A - Inhalational:
- Sevoflurane 2-3% in O₂/air (or O₂/N₂O if N₂O used - though avoidance of N₂O recommended on environmental grounds per Barash 43, p.3699)
- Target MAC 1.0-1.2 adjusted for procedure stimulation
- Desflurane is avoided in children: causes airway irritability and is a potent greenhouse gas
Option B - TIVA (especially for ENT or airway surgery):
- Propofol infusion: Initial rate 15 mg/kg/hr (250 mcg/kg/min) for sedation/TIVA, titrated down; maintenance typically 6-12 mg/kg/hr once steady state
- Plus remifentanil infusion 0.05-0.3 mcg/kg/min for analgesia and blunting of reflexes
Analgesic adjuncts:
| Drug | Dose for 10 kg | Route | Notes |
|---|
| Paracetamol | 15 mg/kg = 150 mg | IV/oral | Q6h, max 60 mg/kg/day |
| Ketorolac | 0.5 mg/kg = 5 mg | IV | Max 30 mg; caution in asthmatics, bleeding risk |
| Morphine | 0.05-0.1 mg/kg = 0.5-1 mg | IV titrated | Careful with apnoea in young children |
| Fentanyl | 1-2 mcg/kg = 10-20 mcg | IV | Shorter acting, less histamine |
Antiemetics:
- Ondansetron 0.1 mg/kg IV = 1 mg (max 4 mg) - prophylaxis if high PONV risk (ENT, strabismus, opioids)
- Dexamethasone 0.15 mg/kg IV = 1.5 mg - dual role: antiemetic + reduces emergence delirium
6. Fluid Management
Maintenance (Holliday-Segar):
- For 10 kg: 100 mL/kg/day = 100 mL/hr first 10 kg = ~42 mL/hr
Intraoperative:
- Balanced crystalloid (Hartmann's/Ringer's lactate or PlasmaLyte) preferred
- Avoid glucose-containing solutions routinely (risk of hyperglycaemia), unless fasting >8 hours or neonates
- Replace third-space losses based on procedure
Transfusion trigger:
- Hb transfusion trigger generally 7-8 g/dL in healthy children (lower in cardiac disease)
- Estimated blood volume (EBV) for 3-year-old = ~75 mL/kg = 750 mL
7. Monitoring (AAGBI minimum standards)
- SpO₂ (pulse oximetry)
- Capnography (ETCO₂) - mandatory when airway secured
- ECG
- NIBP every 3-5 min
- Temperature (children are prone to hypothermia - warm room, warm fluids, Bair Hugger/forced air warming, warm IV fluids)
- Peripheral nerve stimulator if neuromuscular blockade used
8. Emergence & Recovery
- Emergence delirium is common in 2-5 year olds: prevention with dexmedetomidine 0.3-0.5 mcg/kg IV at end of case, or with TIVA (propofol reduces incidence vs. volatile)
- Extubate either awake (preferred in full stomach, airway surgery) or deep (less coughing/laryngospasm for routine cases) - institutional and clinical decision
- Laryngospasm is the most feared PRAE at emergence: treat with CPAP, jaw thrust, propofol 0.5 mg/kg IV; have suxamethonium 2 mg/kg ready (20 mg)
- Stridor post-extubation: nebulised adrenaline 0.5 mL/kg of 1:1000 (max 5 mL), dexamethasone 0.6 mg/kg
PACU:
- Standard monitoring, supplemental O₂
- Pain assessment with FLACC score
- Oral paracetamol/NSAID for breakthrough pain
9. Emergency Drugs (pre-drawn, labelled)
| Drug | Dose | Volume (10 kg) |
|---|
| Atropine 0.6 mg/mL | 0.02 mg/kg | 0.33 mL |
| Adrenaline 1:10,000 | 0.01 mg/kg (cardiac arrest) | 1 mL |
| Suxamethonium 50 mg/mL | 2 mg/kg | 0.4 mL |
| Propofol 10 mg/mL | 0.5 mg/kg (laryngospasm) | 0.5 mL |
| Sugammadex 200 mg/2 mL | 2 mg/kg reversal / 16 mg/kg RSI reversal | 0.1 mL / 0.8 mL |
10. Key Paediatric-Specific Pitfalls
- Rapid desaturation - small FRC relative to oxygen demand; pre-oxygenate well (THRIVE/high-flow if available for anticipated difficult airway)
- Hypothermia - high surface area:body mass ratio; actively warm from pre-induction
- Bradycardia - cardiac output is heart-rate dependent in young children; have atropine ready
- Laryngospasm - peak incidence 2-6 years; URTI increases risk 10-fold
- Drug dosing errors - always calculate per kg before drawing up; use a weight-based reference card
- Undiagnosed myopathy - avoid routine suxamethonium; treat unexplained masseter spasm or tachycardia as MH until proven otherwise
Sources: Barash, Cullen & Stoelting's Clinical Anesthesia, 9e, Chapter 43 (Pediatric Anesthesia); Morgan & Mikhail's Clinical Anesthesiology, 7e, Chapter 54; PMC premedication review